Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021
Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1253-1253
Open Access | Times Cited: 126
Neoadjuvant or adjuvant chemotherapy in early breast cancer?
Filippo Montemurro, Imperia Nuzzolese, Riccardo Ponzone
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 9, pp. 1071-1082
Closed Access | Times Cited: 95
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
Desh Deepak Singh, Dharmendra Kumar Yadav
Biomedicines (2021) Vol. 9, Iss. 8, pp. 876-876
Open Access | Times Cited: 64
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies
Antonio Russo, Lorena Incorvaia, Ettore Capoluongo, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100459-100459
Open Access | Times Cited: 48
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors
Giovanna Garufi, Antonella Palazzo, Ida Paris, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 6, pp. 687-699
Closed Access | Times Cited: 56
Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer
Pengjun Qiu, Qiao‐Nan Guo, Qingzhi Yao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Homologous Recombination Deficiency (HRD) and BRCA 1/2 Gene Mutation for Predicting the Effect of Platinum-Based Neoadjuvant Chemotherapy of Early-Stage Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis
Yue Chai, Yujie Chen, Di Zhang, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 323-323
Open Access | Times Cited: 26
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review
Hao Tian, Dandan Ma, Xuanni Tan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
Zundong Liu, Mingji Ding, Pengjun Qiu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Current landscape of personalized clinical treatments for triple-negative breast cancer
Jun Zhang, Yu Xia, Xiaomei Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Emerging treatment approaches for triple-negative breast cancer
Maurizio Capuozzo, Venere Celotto, Mariachiara Santorsola, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
Exploring Mechanism of Key Chinese Herbal Medicine on Breast Cancer by Data Mining and Network Pharmacology Methods
Lina Yang, Zhulin Wu, Zhenjiang Yang, et al.
Chinese Journal of Integrative Medicine (2020) Vol. 27, Iss. 12, pp. 919-926
Closed Access | Times Cited: 25
Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
Qian Hao, Luyao Dai, Lidan Chang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Recent advances in neoadjuvant therapy for breast cancer
David A. Potter, César A Herrera-Ponzanelli, Diego Hinojosa Ugarte, et al.
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 16
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study
Elisabetta Rossi, Alessandra Invento, Filippo Pesapane, et al.
British journal of surgery (2022) Vol. 110, Iss. 2, pp. 217-224
Open Access | Times Cited: 9
The inhibitory effect and mechanism of Resina Draconis on the proliferation of MCF-7 breast cancer cells: a network pharmacology-based analysis
Yana Lv, Yan Mou, Jing Su, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
Benjamín Walbaum, Francisco Acevedo, Lidia Medina, et al.
ecancermedicalscience (2021) Vol. 15
Open Access | Times Cited: 9
A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer
Pengjun Qiu, Qiao‐Nan Guo, Kelun Pan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 190, pp. 104086-104086
Open Access | Times Cited: 3
Invasive Ductal Breast Cancer with Osteoclast-Like Giant Cells: A Case Report Based on the Gene Expression Profile for Changes in Management
Azzurra Irelli, Maria Maddalena Sirufo, Gina Rosaria Quaglione, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 156-156
Open Access | Times Cited: 3
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer
Carla Corvaja, Mattia Garutti, Lorenzo Gerratana, et al.
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 12, pp. 1005-1008
Open Access | Times Cited: 2
The Inhibitory Effect of Resina draconis on the Proliferation of MCF-7 Breast Cancer Cells, and its Mechanism: An Investigation Using Network Pharmacology-Based Analysis
Yana Lv, Yan Mou, Jing Su, et al.
Research Square (Research Square) (2022)
Open Access
Adjuvant Versus Neoadjuvant Systemic Therapy
Beth Overmoyer
Springer eBooks (2021), pp. 151-167
Closed Access
Page 1

Scroll to top